Sloan Fellows

Odyssey Therapeutics Appoints Julie Clauss as Chief Operating Officer and Christopher Butler as SVP, Head of Chemistry

Retrieved on: 
Tuesday, April 2, 2024
Biotechnology, FDA, Health, General Health, Pharmaceutical, Oncology, Research, Infectious Diseases, Genetics, Science, Clinical Trials, Culture, Sanofi Pasteur, Drug discovery, Business administration, Patient, SVP, Gene, Joseph Fourier University, Standard of care, Cancer, University, Record, Inflammation, MBA, Therapy, Sloan Fellows, Research and development, Multimedia, Vertex Pharmaceuticals, Physical, Management

Odyssey Therapeutics, Inc. , a biotechnology company pioneering next-generation precision immunomodulators and oncology medicines, today announced the appointment of Julie Clauss, MBA, as chief operating officer and Christopher Butler, Ph.D., as senior vice president (SVP), head of Chemistry.

Key Points: 
  • Odyssey Therapeutics, Inc. , a biotechnology company pioneering next-generation precision immunomodulators and oncology medicines, today announced the appointment of Julie Clauss, MBA, as chief operating officer and Christopher Butler, Ph.D., as senior vice president (SVP), head of Chemistry.
  • Together, these individuals bring more than 40 years of leadership experience and scientific expertise within the biotechnology and pharmaceutical industries to Odyssey.
  • Clauss and Dr. Butler have proven track records of successfully leading teams to achieve strategic business and research goals.
  • Ms. Clauss received a Master of Business Administration through the Sloan Fellows program at the Massachusetts Institute of Technology.

NanoXplore wins new business representing $24M in annual sales at mature volumes and announces the nomination of Jesse Stanley, COO of Shell Energy, to its board of directors

Retrieved on: 
Wednesday, September 20, 2023
Shell, Marketing, Shell plc, Sloan Fellows, Carbon, Plant, Lubricant, Corporation, Stanford Graduate School of Business, Investment, OTCQX, United Kingdom, TSX, Auto, OEM, Transport, Management

Production for the first program will begin in 2024 while the start of production for the other two programs is planned for 2026.

Key Points: 
  • Production for the first program will begin in 2024 while the start of production for the other two programs is planned for 2026.
  • The Corporation estimates that these programs will generate $24M in annual sales at mature volumes along with a one-time tooling revenue of $10M.
  • Jesse C. H. Stanley has worked for Shell Energy North America, LLC as Chief Operations Officer since 2021.
  • Her broad range of experience in strategy, sales and marketing and supply chain operations will be beneficial to NanoXplore.”

DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary

Retrieved on: 
Wednesday, September 6, 2023
Money, Operation, Private sector, Executive, Responsibility, Market, Fordham University, Senior, Mutual, Bloomberg L.P., National University of Singapore, National university, London Business School, CMT Association, Sloan Fellows, Wall Street, MAS, Chase Bank, CMT, Monetary Authority of Singapore, AIG, Government, Chemistry, Global Association of Risk Professionals, Tableau, Bloomberg, The Best Job in the World (advertising), Mutual of America, Chartered Financial Analyst, System, American International Group, Industries, commerce and investment department (Punjab, Pakistan), DSS, Management, New York University

Jim Monaghan has joined DSS Wealth Management as Chief Operating Officer and Chief Compliance Officer reporting to Daniel Lew.

Key Points: 
  • Jim Monaghan has joined DSS Wealth Management as Chief Operating Officer and Chief Compliance Officer reporting to Daniel Lew.
  • He started his career in the annuity business as an equity trader for pension funds at Mutual of America Life Insurance Company.
  • Jim continued his career as an equity trader at Chase Bank working on their dealer trading floor on Wall Street.
  • This talented team has a proven track record of measurable success and high performance backed by a reliable reputation needed to maximize value for DSS shareholders.”

Perimeter Medical Imaging AI Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, August 29, 2023
Mayo Clinic, Certified Management Accountant, Surgeon, CMA, Meta, University, International, International Accounting Standards Committee, Classification, Baylor College of Medicine, London Business School, Principal investigator, Clinical trial, Baylor University, Perimeter, Master, Sloan Fellows, FSE, Management science, ID, InterAction Council of Former Heads of State and Government, Baptists, Patient, International Financial Reporting Standards, Engineering, OCT, OTC, Webcast, CFO, Association of British HealthTech Industries, IAS, FDA, PINK, Medtech, International Accounting Standards Board, Management, Medical device, Cryptocurrency, DALLAS, Science

TORONTO and DALLAS, Aug. 29, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its second quarter ended June 30, 2023 and provided a corporate update.

Key Points: 
  • TORONTO and DALLAS, Aug. 29, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its second quarter ended June 30, 2023 and provided a corporate update.
  • In addition, I am pleased to report that Sara Brien will become Perimeter's Chief Financial Officer, effective September 1, 2023.
  • The study is evaluating the use of Perimeter B-Series OCT combined with its proprietary ImgAssist AI software during breast conservation surgery.
  • The Company will host a conference call and live audio webcast today, Tuesday, August 29, 2023, at 5:00 pm Eastern Time to discuss its second quarter 2023 results and to provide a corporate update.

Kytopen Names Michael Chiu, Ph.D., as Chief Executive Officer

Retrieved on: 
Monday, August 7, 2023
University, Sigma-Aldrich, AUC, Marketing, Biotechnology, Innovation system, Merck Group, MIT, Patient, Growth, Teradyne, Cell engineering, Sloan Fellows, Pharmaceutical industry

CAMBRIDGE, Mass., Aug. 7, 2023 /PRNewswire/ -- Kytopen, a biotechnology company that develops and markets advanced cell engineering solutions, today announced the appointment of Michael Chiu, Ph.D., as Chief Executive Officer. An entrepreneurial leader with extensive experience in building and commercializing new technologies, he brings to Kytopen a proven track record in fundraising, product development, and marketing launches. Dr. Chiu succeeds Paulo A. Garcia, Ph.D., one of the company's co-founders, who will continue as an advisor.

Key Points: 
  • CAMBRIDGE, Mass., Aug. 7, 2023 /PRNewswire/ -- Kytopen, a biotechnology company that develops and markets advanced cell engineering solutions, today announced the appointment of Michael Chiu, Ph.D., as Chief Executive Officer.
  • Dr. Chiu joins Kytopen at the time of its accelerated roll-out of the Flowfect® technology to high-profile academic medical centers in the U.S.
  • Prior to this, he was the Chief Executive Officer of Erbi Biosystems, Inc., which was acquired by Merck KGaA, Darmstadt Germany (MilliporeSigma in US), last year.
  • Earlier in his career, he was a chief technology officer and senior executive with several high-tech companies, including Automation Engineering Inc. (acquired by Mycronic AB), Trophos Energy, and Teradyne.

Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors

Retrieved on: 
Thursday, May 25, 2023
Biotechnology, Health, Genetics, Pharmaceutical, Clinical Trials, Yale University, Poverty, MIT Sloan School of Management, Board for Industrial and Financial Reconstruction, Roche, CAH, Congenital adrenal hyperplasia, Sloan Fellows, Innovation, Polycystic ovary syndrome, Astellas Pharma, Patient, Chemistry, Therapy, Cornell University, Pharmaceutical industry, Management, AmeriCares, Spruce

(Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced the appointment of Percival Barretto-Ko to the company’s Board of Directors.

Key Points: 
  • (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced the appointment of Percival Barretto-Ko to the company’s Board of Directors.
  • Concurrently, Dina Chaya, Ph.D., has stepped down from the Board of Directors.
  • “On behalf of Spruce, I am pleased to welcome Percival Barretto-Ko to our Board of Directors,” said Mike Grey, Executive Chairman of Spruce Biosciences.
  • Prior to joining Astellas, Mr. Barretto-Ko served in increasingly senior roles at Roche UK and US from 2001 to 2005.

Woodward Announces Two Appointments to Board of Directors: Mary Petryszyn and Tana Utley

Retrieved on: 
Wednesday, May 10, 2023
Aircraft, SWE, Bradley University, Society, Northrop Grumman, Defense, WWD, Clarkson University, Hughes Aircraft Company, Tana, Caterpillar Inc., Sloan Fellows, United Service Organizations, NASA RealWorld-InWorld Engineering Design Challenge, Grumman, USO, Electricity, Government, Electronic, Manager, Utley, National Science Board, Syracuse University, Woodward, Inc., C4ISR, Corporation, Caterpillar, Federal Reserve Board of Governors, Raytheon Technologies, Woman, Massachusetts Institute of Technology, Chair, Engine, Management

“They bring deep expertise to their roles as directors, developed through their impressive careers as leaders in aerospace and industrial sectors.

Key Points: 
  • “They bring deep expertise to their roles as directors, developed through their impressive careers as leaders in aerospace and industrial sectors.
  • Petryszyn’s extensive global experience in government and defense markets also includes previous leadership roles at Singer-Link, Hughes Aircraft Company, and Raytheon.
  • Petryszyn serves on the Board of Directors for Saab Inc. and the Board of Governors of the United Service Organizations (USO).
  • Utley currently serves on the board of SPX Technologies Inc. She holds a B.S.

PLS Expands Corporate M&A Team with SVP Hire Mark Kummer

Retrieved on: 
Wednesday, November 16, 2022
Technology, Acquisition, Transport, Corporate development, Sloan Fellows, MBA, Senior, Industry, MIT, View, PLS Logistics, LTL, Multimedia, Culture, MIT Sloan School of Management, FLS, Atmosphere, Solution, Management, Security (finance)

CRANBERRY TWP., Pa., Nov. 16, 2022 /PRNewswire/ -- PLS Logistics Services, a leading, technology-driven, third-party logistics services provider, has announced the hire of industry veteran Mark Kummer as Senior Vice President of Corporate Development.

Key Points: 
  • CRANBERRY TWP., Pa., Nov. 16, 2022 /PRNewswire/ -- PLS Logistics Services, a leading, technology-driven, third-party logistics services provider, has announced the hire of industry veteran Mark Kummer as Senior Vice President of Corporate Development.
  • Mr. Kummer, most recently a Sloan Fellow at the MIT-Sloan School of Management, will lead PLS Logistics Services' merger and acquisition team.
  • Mr. Kummer brings over 20 years of industry experience, including senior growth positions at non-asset and asset-based companies within the industry.
  • "Throughout his career, Mr. Kummer has a proven record of navigating markets and increasing revenue," said PLS Logistics Services Chairman, President, and CEO Greg Burns.

The National Black MBA Association® (NBMBAA®) to Announce Michael E. Hamilton as New Board Chair During Its 44th Annual Conference and Expo at The Georgia World Congress Center September 27-October 1

Retrieved on: 
Friday, September 30, 2022
Ordway Center for the Performing Arts, Twitter, Computer, Lifetime, Association, Electrical engineering, Empowerment, LinkedIn, NBMBAA, National Black MBA Association, Electricity, Policy, London Business School, Business, Entrepreneurship, Minneapolis–Saint Paul, Instagram, Student, Bachelor of Science, Chairperson, Association of Performing Arts Professionals, Board, Champaign County, Illinois, Sloan Fellows, Bachelor, Black, Conference, Congress Center, University, Education, Georgia World Congress Center, ELC, Management, Science, Facebook, Leadership

ATLANTA, Sept. 30, 2022 /PRNewswire/ -- The National Black MBA Association (NBMBAA) will formally announce Michael E. Hamilton as the new board chair on October 1 during its 44th Annual Conference and Expo at the Georgia World Congress Center in Atlanta.

Key Points: 
  • ATLANTA, Sept. 30, 2022 /PRNewswire/ -- The National Black MBA Association (NBMBAA) will formally announce Michael E. Hamilton as the new board chair on October 1 during its 44th Annual Conference and Expo at the Georgia World Congress Center in Atlanta.
  • Hamilton currently serves on the Board of Directors for The University of Northern Iowa College of Business.
  • Hamilton, who is a Board Member and Lifetime Member of the National Black MBA Association and a member of the Executive Leadership Council (ELC), is looking forward to his new position and serving the organization in a leadership capacity.
  • "Chairman Butts has been an inspiration to the NBMBAA," said Shawn Graham, who currently serves as The National Black MBA Association Interim Chief Executive Officer.

William J. Amelio Named Honoree Of 2022 Columbus Celebration Weekend

Retrieved on: 
Thursday, August 11, 2022
Chemical engineering, Dell, Stanford Graduate School of Business, Lenovo, Industry, CEO, IBM, Senior, Sloan Fellows, NEW, Lehigh University, NSF, Leadership, Business, Grand, Achievement, Financial institution, Foundation, 44th Street Theatre, Fifth Avenue, Honeywell, Executive, Director, 72nd Street station, Columbus Citizens Foundation, National Semiconductor, Culture, EDT, NCR Corporation, Stanford Graduate School of Education, Student, CHC, Entertainment, Management, Amelio, Avnet

NEW YORK, Aug. 11, 2022 /PRNewswire-PRWeb/ -- Columbus Citizens Foundation today announced William (Bill) Amelio as an Honoree of the 2022 Columbus Celebration. Amelio, Executive Chairman & Co-CEO of financial start-up DoubleCheck Solutions, will join Tom Golisano, who was previously announced as the 2022 Grand Marshal.

Key Points: 
  • William J. Amelio, Executive Chairman and Co-CEO of DoubleCheck Solutions, will join Grand Marshal Tom Golisano in Columbus Citizens Foundation's 2022 Columbus Weekend Celebration
    NEW YORK, Aug. 11, 2022 /PRNewswire-PRWeb/ -- Columbus Citizens Foundation today announced William (Bill) Amelio as an Honoree of the 2022 Columbus Celebration.
  • Amelio, Executive Chairman & Co-CEO of financial start-up DoubleCheck Solutions, will join Tom Golisano, who was previously announced as the 2022 Grand Marshal.
  • Mr. Amelio commented; "As an Italian American, I could not be happier to be named as an Honoree for the 2022 Columbus Celebration.
  • The Foundation organizes New York City's annual Columbus Celebration and Columbus Day Parade, which has celebrated Italian-American heritage on New York's Fifth Avenue since 1929.